Andrew C. Wiechert

Andrew C. Wiechert

Obstetrics and Gynecology
482 Bedford Street
Lexington, MA 02420

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Correction: CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors.

Correction: CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors.

Journal: The Journal of experimental medicine
Published: July 30, 2026

Comparative analysis of adjuvant treatment outcomes in stage III endometrial cancer: overall survival, recurrence-free survival, site of primary recurrence, and toxicity.

Comparative analysis of adjuvant treatment outcomes in stage III endometrial cancer: overall survival, recurrence-free survival, site of primary recurrence, and toxicity.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 21, 2025

General Versus Local Anesthesia in Loop Electrosurgical Excision Procedures: A Systematic Review and Meta-Analysis.

General Versus Local Anesthesia in Loop Electrosurgical Excision Procedures: A Systematic Review and Meta-Analysis.

Journal: Journal of lower genital tract disease
Published: November 04, 2024

Implementation of a financial navigation program in gynecologic oncology.

Implementation of a financial navigation program in gynecologic oncology.

Journal: Gynecologic oncology
Published: April 26, 2024

Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer.

Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer.

Journal: Journal of ovarian research
Published: June 27, 2019

CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors.

CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors.

Journal: The Journal of experimental medicine
Published: March 08, 2017

Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase.

Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase.

Journal: Nature communications
Published: December 20, 2016

The Impact of Obesity on the 30-day Morbidity and Mortality After Surgery for Ovarian Cancer.

The Impact of Obesity on the 30-day Morbidity and Mortality After Surgery for Ovarian Cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: January 26, 2016

Cisplatin induces stemness in ovarian cancer.

Cisplatin induces stemness in ovarian cancer.

Journal: Oncotarget
Published: December 01, 2015

Impact of Age on 30-Day Mortality and Morbidity in Patients Undergoing Surgery for Ovarian Cancer.

Impact of Age on 30-Day Mortality and Morbidity in Patients Undergoing Surgery for Ovarian Cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 16, 2015

Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.

Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.

Journal: Stem cells (Dayton, Ohio)
Published: August 07, 2014

Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgical cytoreduction for epithelial ovarian carcinoma.

Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgical cytoreduction for epithelial ovarian carcinoma.

Journal: Gynecologic oncology
Published: April 03, 2013
Showing 1-12 of 13

Last Updated: 09/26/2026